We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TGA Clarifies Conflict of Interest Rules for Advisory Panels
TGA Clarifies Conflict of Interest Rules for Advisory Panels
January 10, 2012
Drug advisory committee members should disclose any potential conflict of interest prior to each meeting, according to a final guideline by Australia’s Therapeutic Goods Administration (TGA).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor